Portal de Periódicos da CAPES

Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant

2019; Wolters Kluwer; Volume: 98; Issue: 7 Linguagem: Inglês

10.1097/md.0000000000014559

1536-5964

Danbi Kim, Ju Ae Shin, Seung Beom Han, Nack‐Gyun Chung, Dae Chul Jeong,

Blood disorders and treatments

Pneumocystis jirovecii causes severe pneumonia in immunocompromised hosts. Human immunodeficiency virus infection, malignancy, solid organ or hematopoietic cell transplantation, and primary immune deficiency compose the risk factors for Pneumocystis pneumonia (PCP) in children, and PCP can be an initial clinical manifestation of primary immune deficiency.A 5-month-old infant presented with cyanosis and tachypnea. He had no previous medical or birth history suggesting primary immune deficiency. He was diagnosed with interstitial pneumonia on admission.He was diagnosed with PCP, and further evaluations revealed underlying X-linked hyper-IgM syndrome.He was treated with trimethoprim/sulfamethoxazole for PCP, and eventually received allogeneic hematopoietic cell transplantation for hyper-IgM syndrome.Twenty months have passed after transplantation without severe complications.PCP should be considered in infants presenting with severe interstitial pneumonia even in the absence of evidence of immune deficiency. Primary immune deficiency should also be suspected in infants diagnosed with PCP.